Global Follicle Stimulating Hormone Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 94

Published Date: 04 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Follicle Stimulating Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Follicle Stimulating Hormone market size is estimated to be worth US$ 1312 million in 2021 and is forecast to a readjusted size of USD 1578.8 million by 2028 with a CAGR of 2.7% during review period. Infertility Treatment accounting for % of the Follicle Stimulating Hormone global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Recombinant FSH segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Follicle Stimulating Hormone include Merck Serono, MSD, IBSA, Ferring, and Livzon, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Follicle Stimulating Hormone market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Recombinant FSH
    Urinary FSH

Market segment by Application can be divided into
    Infertility Treatment
    Assisted Reproductive Technology

The key market players for global Follicle Stimulating Hormone market are listed below:
    Merck Serono
    MSD
    IBSA
    Ferring
    Livzon
    Techwell
    GenSci
    Gedeon Richter
    Teva

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Follicle Stimulating Hormone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Follicle Stimulating Hormone, with price, sales, revenue and global market share of Follicle Stimulating Hormone from 2019 to 2022.
Chapter 3, the Follicle Stimulating Hormone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Follicle Stimulating Hormone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Follicle Stimulating Hormone market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Follicle Stimulating Hormone.
Chapter 13, 14, and 15, to describe Follicle Stimulating Hormone sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Follicle Stimulating Hormone Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Follicle Stimulating Hormone Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Recombinant FSH
        1.2.3 Urinary FSH
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Follicle Stimulating Hormone Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Infertility Treatment
        1.3.3 Assisted Reproductive Technology
    1.4 Global Follicle Stimulating Hormone Market Size & Forecast
        1.4.1 Global Follicle Stimulating Hormone Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Follicle Stimulating Hormone Sales in Volume (2017-2028)
        1.4.3 Global Follicle Stimulating Hormone Price (2017-2028)
    1.5 Global Follicle Stimulating Hormone Production Capacity Analysis
        1.5.1 Global Follicle Stimulating Hormone Total Production Capacity (2017-2028)
        1.5.2 Global Follicle Stimulating Hormone Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Follicle Stimulating Hormone Market Drivers
        1.6.2 Follicle Stimulating Hormone Market Restraints
        1.6.3 Follicle Stimulating Hormone Trends Analysis

2 Manufacturers Profiles
    2.1 Merck Serono
        2.1.1 Merck Serono Details
        2.1.2 Merck Serono Major Business
        2.1.3 Merck Serono Follicle Stimulating Hormone Product and Services
        2.1.4 Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 MSD
        2.2.1 MSD Details
        2.2.2 MSD Major Business
        2.2.3 MSD Follicle Stimulating Hormone Product and Services
        2.2.4 MSD Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 IBSA
        2.3.1 IBSA Details
        2.3.2 IBSA Major Business
        2.3.3 IBSA Follicle Stimulating Hormone Product and Services
        2.3.4 IBSA Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Ferring
        2.4.1 Ferring Details
        2.4.2 Ferring Major Business
        2.4.3 Ferring Follicle Stimulating Hormone Product and Services
        2.4.4 Ferring Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Livzon
        2.5.1 Livzon Details
        2.5.2 Livzon Major Business
        2.5.3 Livzon Follicle Stimulating Hormone Product and Services
        2.5.4 Livzon Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Techwell
        2.6.1 Techwell Details
        2.6.2 Techwell Major Business
        2.6.3 Techwell Follicle Stimulating Hormone Product and Services
        2.6.4 Techwell Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 GenSci
        2.7.1 GenSci Details
        2.7.2 GenSci Major Business
        2.7.3 GenSci Follicle Stimulating Hormone Product and Services
        2.7.4 GenSci Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Gedeon Richter
        2.8.1 Gedeon Richter Details
        2.8.2 Gedeon Richter Major Business
        2.8.3 Gedeon Richter Follicle Stimulating Hormone Product and Services
        2.8.4 Gedeon Richter Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Teva
        2.9.1 Teva Details
        2.9.2 Teva Major Business
        2.9.3 Teva Follicle Stimulating Hormone Product and Services
        2.9.4 Teva Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Follicle Stimulating Hormone Breakdown Data by Manufacturer
    3.1 Global Follicle Stimulating Hormone Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Follicle Stimulating Hormone Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Follicle Stimulating Hormone
    3.4 Market Concentration Rate
        3.4.1 Top 3 Follicle Stimulating Hormone Manufacturer Market Share in 2021
        3.4.2 Top 6 Follicle Stimulating Hormone Manufacturer Market Share in 2021
    3.5 Global Follicle Stimulating Hormone Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Follicle Stimulating Hormone Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Follicle Stimulating Hormone Market Size by Region
        4.1.1 Global Follicle Stimulating Hormone Sales in Volume by Region (2017-2028)
        4.1.2 Global Follicle Stimulating Hormone Revenue by Region (2017-2028)
    4.2 North America Follicle Stimulating Hormone Revenue (2017-2028)
    4.3 Europe Follicle Stimulating Hormone Revenue (2017-2028)
    4.4 Asia-Pacific Follicle Stimulating Hormone Revenue (2017-2028)
    4.5 South America Follicle Stimulating Hormone Revenue (2017-2028)
    4.6 Middle East and Africa Follicle Stimulating Hormone Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Follicle Stimulating Hormone Sales in Volume by Type (2017-2028)
    5.2 Global Follicle Stimulating Hormone Revenue by Type (2017-2028)
    5.3 Global Follicle Stimulating Hormone Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Follicle Stimulating Hormone Sales in Volume by Application (2017-2028)
    6.2 Global Follicle Stimulating Hormone Revenue by Application (2017-2028)
    6.3 Global Follicle Stimulating Hormone Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Follicle Stimulating Hormone Sales by Type (2017-2028)
    7.2 North America Follicle Stimulating Hormone Sales by Application (2017-2028)
    7.3 North America Follicle Stimulating Hormone Market Size by Country
        7.3.1 North America Follicle Stimulating Hormone Sales in Volume by Country (2017-2028)
        7.3.2 North America Follicle Stimulating Hormone Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Follicle Stimulating Hormone Sales by Type (2017-2028)
    8.2 Europe Follicle Stimulating Hormone Sales by Application (2017-2028)
    8.3 Europe Follicle Stimulating Hormone Market Size by Country
        8.3.1 Europe Follicle Stimulating Hormone Sales in Volume by Country (2017-2028)
        8.3.2 Europe Follicle Stimulating Hormone Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Follicle Stimulating Hormone Sales by Type (2017-2028)
    9.2 Asia-Pacific Follicle Stimulating Hormone Sales by Application (2017-2028)
    9.3 Asia-Pacific Follicle Stimulating Hormone Market Size by Region
        9.3.1 Asia-Pacific Follicle Stimulating Hormone Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Follicle Stimulating Hormone Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Follicle Stimulating Hormone Sales by Type (2017-2028)
    10.2 South America Follicle Stimulating Hormone Sales by Application (2017-2028)
    10.3 South America Follicle Stimulating Hormone Market Size by Country
        10.3.1 South America Follicle Stimulating Hormone Sales in Volume by Country (2017-2028)
        10.3.2 South America Follicle Stimulating Hormone Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Follicle Stimulating Hormone Sales by Type (2017-2028)
    11.2 Middle East & Africa Follicle Stimulating Hormone Sales by Application (2017-2028)
    11.3 Middle East & Africa Follicle Stimulating Hormone Market Size by Country
        11.3.1 Middle East & Africa Follicle Stimulating Hormone Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Follicle Stimulating Hormone Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Follicle Stimulating Hormone and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Follicle Stimulating Hormone
    12.3 Follicle Stimulating Hormone Production Process
    12.4 Follicle Stimulating Hormone Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Follicle Stimulating Hormone Typical Distributors
    13.3 Follicle Stimulating Hormone Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Follicle Stimulating Hormone Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Follicle Stimulating Hormone Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Merck Serono Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Serono Major Business
    Table 5. Merck Serono Follicle Stimulating Hormone Product and Services
    Table 6. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. MSD Basic Information, Manufacturing Base and Competitors
    Table 8. MSD Major Business
    Table 9. MSD Follicle Stimulating Hormone Product and Services
    Table 10. MSD Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. IBSA Basic Information, Manufacturing Base and Competitors
    Table 12. IBSA Major Business
    Table 13. IBSA Follicle Stimulating Hormone Product and Services
    Table 14. IBSA Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Ferring Basic Information, Manufacturing Base and Competitors
    Table 16. Ferring Major Business
    Table 17. Ferring Follicle Stimulating Hormone Product and Services
    Table 18. Ferring Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Livzon Basic Information, Manufacturing Base and Competitors
    Table 20. Livzon Major Business
    Table 21. Livzon Follicle Stimulating Hormone Product and Services
    Table 22. Livzon Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Techwell Basic Information, Manufacturing Base and Competitors
    Table 24. Techwell Major Business
    Table 25. Techwell Follicle Stimulating Hormone Product and Services
    Table 26. Techwell Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. GenSci Basic Information, Manufacturing Base and Competitors
    Table 28. GenSci Major Business
    Table 29. GenSci Follicle Stimulating Hormone Product and Services
    Table 30. GenSci Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Gedeon Richter Basic Information, Manufacturing Base and Competitors
    Table 32. Gedeon Richter Major Business
    Table 33. Gedeon Richter Follicle Stimulating Hormone Product and Services
    Table 34. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Teva Basic Information, Manufacturing Base and Competitors
    Table 36. Teva Major Business
    Table 37. Teva Follicle Stimulating Hormone Product and Services
    Table 38. Teva Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Global Follicle Stimulating Hormone Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
    Table 40. Global Follicle Stimulating Hormone Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 41. Market Position of Manufacturers in Follicle Stimulating Hormone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 42. Global Follicle Stimulating Hormone Production Capacity by Company, (K Doses): 2020 VS 2021
    Table 43. Head Office and Follicle Stimulating Hormone Production Site of Key Manufacturer
    Table 44. Follicle Stimulating Hormone New Entrant and Capacity Expansion Plans
    Table 45. Follicle Stimulating Hormone Mergers & Acquisitions in the Past Five Years
    Table 46. Global Follicle Stimulating Hormone Sales by Region (2017-2022) & (K Doses)
    Table 47. Global Follicle Stimulating Hormone Sales by Region (2023-2028) & (K Doses)
    Table 48. Global Follicle Stimulating Hormone Revenue by Region (2017-2022) & (USD Million)
    Table 49. Global Follicle Stimulating Hormone Revenue by Region (2023-2028) & (USD Million)
    Table 50. Global Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 51. Global Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 52. Global Follicle Stimulating Hormone Revenue by Type (2017-2022) & (USD Million)
    Table 53. Global Follicle Stimulating Hormone Revenue by Type (2023-2028) & (USD Million)
    Table 54. Global Follicle Stimulating Hormone Price by Type (2017-2022) & (USD/Dose)
    Table 55. Global Follicle Stimulating Hormone Price by Type (2023-2028) & (USD/Dose)
    Table 56. Global Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 57. Global Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 58. Global Follicle Stimulating Hormone Revenue by Application (2017-2022) & (USD Million)
    Table 59. Global Follicle Stimulating Hormone Revenue by Application (2023-2028) & (USD Million)
    Table 60. Global Follicle Stimulating Hormone Price by Application (2017-2022) & (USD/Dose)
    Table 61. Global Follicle Stimulating Hormone Price by Application (2023-2028) & (USD/Dose)
    Table 62. North America Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
    Table 63. North America Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
    Table 64. North America Follicle Stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 65. North America Follicle Stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 66. North America Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 67. North America Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 68. North America Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 69. North America Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 70. Europe Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
    Table 71. Europe Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
    Table 72. Europe Follicle Stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 73. Europe Follicle Stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 74. Europe Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 75. Europe Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 76. Europe Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 77. Europe Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 78. Asia-Pacific Follicle Stimulating Hormone Sales by Region (2017-2022) & (K Doses)
    Table 79. Asia-Pacific Follicle Stimulating Hormone Sales by Region (2023-2028) & (K Doses)
    Table 80. Asia-Pacific Follicle Stimulating Hormone Revenue by Region (2017-2022) & (USD Million)
    Table 81. Asia-Pacific Follicle Stimulating Hormone Revenue by Region (2023-2028) & (USD Million)
    Table 82. Asia-Pacific Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 83. Asia-Pacific Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 84. Asia-Pacific Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 85. Asia-Pacific Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 86. South America Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
    Table 87. South America Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
    Table 88. South America Follicle Stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 89. South America Follicle Stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 90. South America Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 91. South America Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 92. South America Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 93. South America Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 94. Middle East & Africa Follicle Stimulating Hormone Sales by Region (2017-2022) & (K Doses)
    Table 95. Middle East & Africa Follicle Stimulating Hormone Sales by Region (2023-2028) & (K Doses)
    Table 96. Middle East & Africa Follicle Stimulating Hormone Revenue by Region (2017-2022) & (USD Million)
    Table 97. Middle East & Africa Follicle Stimulating Hormone Revenue by Region (2023-2028) & (USD Million)
    Table 98. Middle East & Africa Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 99. Middle East & Africa Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 100. Middle East & Africa Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 101. Middle East & Africa Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 102. Follicle Stimulating Hormone Raw Material
    Table 103. Key Manufacturers of Follicle Stimulating Hormone Raw Materials
    Table 104. Direct Channel Pros & Cons
    Table 105. Indirect Channel Pros & Cons
    Table 106. Follicle Stimulating Hormone Typical Distributors
    Table 107. Follicle Stimulating Hormone Typical Customers
List of Figures
    Figure 1. Follicle Stimulating Hormone Picture
    Figure 2. Global Follicle Stimulating Hormone Revenue Market Share by Type in 2021
    Figure 3. Recombinant FSH
    Figure 4. Urinary FSH
    Figure 5. Global Follicle Stimulating Hormone Revenue Market Share by Application in 2021
    Figure 6. Infertility Treatment
    Figure 7. Assisted Reproductive Technology
    Figure 8. Global Follicle Stimulating Hormone Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
    Figure 9. Global Follicle Stimulating Hormone Revenue and Forecast (2017-2028) & (USD Million)
    Figure 10. Global Follicle Stimulating Hormone Sales (2017-2028) & (K Doses)
    Figure 11. Global Follicle Stimulating Hormone Price (2017-2028) & (USD/Dose)
    Figure 12. Global Follicle Stimulating Hormone Production Capacity (2017-2028) & (K Doses)
    Figure 13. Global Follicle Stimulating Hormone Production Capacity by Geographic Region: 2022 VS 2028
    Figure 14. Follicle Stimulating Hormone Market Drivers
    Figure 15. Follicle Stimulating Hormone Market Restraints
    Figure 16. Follicle Stimulating Hormone Market Trends
    Figure 17. Global Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2021
    Figure 18. Global Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2021
    Figure 19. Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 20. Top 3 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2021
    Figure 21. Top 6 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2021
    Figure 22. Global Follicle Stimulating Hormone Sales Market Share by Region (2017-2028)
    Figure 23. Global Follicle Stimulating Hormone Revenue Market Share by Region (2017-2028)
    Figure 24. North America Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 25. Europe Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 26. Asia-Pacific Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 27. South America Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 28. Middle East & Africa Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 29. Global Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 30. Global Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
    Figure 31. Global Follicle Stimulating Hormone Price by Type (2017-2028) & (USD/Dose)
    Figure 32. Global Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 33. Global Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
    Figure 34. Global Follicle Stimulating Hormone Price by Application (2017-2028) & (USD/Dose)
    Figure 35. North America Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 36. North America Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 37. North America Follicle Stimulating Hormone Sales Market Share by Country (2017-2028)
    Figure 38. North America Follicle Stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 39. United States Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 40. Canada Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Mexico Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Europe Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 43. Europe Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 44. Europe Follicle Stimulating Hormone Sales Market Share by Country (2017-2028)
    Figure 45. Europe Follicle Stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 46. Germany Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. France Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. United Kingdom Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Russia Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Italy Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Asia-Pacific Follicle Stimulating Hormone Sales Market Share by Region (2017-2028)
    Figure 52. Asia-Pacific Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 53. Asia-Pacific Follicle Stimulating Hormone Sales Market Share by Region (2017-2028)
    Figure 54. Asia-Pacific Follicle Stimulating Hormone Revenue Market Share by Region (2017-2028)
    Figure 55. China Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Japan Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Korea Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. India Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Southeast Asia Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Australia Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. South America Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 62. South America Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 63. South America Follicle Stimulating Hormone Sales Market Share by Country (2017-2028)
    Figure 64. South America Follicle Stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 65. Brazil Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Argentina Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 68. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 69. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Region (2017-2028)
    Figure 70. Middle East & Africa Follicle Stimulating Hormone Revenue Market Share by Region (2017-2028)
    Figure 71. Turkey Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Egypt Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Saudi Arabia Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. South Africa Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Manufacturing Cost Structure Analysis of Follicle Stimulating Hormone in 2021
    Figure 76. Manufacturing Process Analysis of Follicle Stimulating Hormone
    Figure 77. Follicle Stimulating Hormone Industrial Chain
    Figure 78. Sales Channel: Direct Channel vs Indirect Channel
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva

Related Reports

Global Follicle Stimulating Hormone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Follicle Stimulating Hormone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 26 Jan 2021

date Pharma & Healthcare

The Follicle Stimulating Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Follicle Stimulating Hormone Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Follicle Stimulating Hormone Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Global Follicle Stimulating Hormone Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Follicle Stimulating Hormone Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Follicle Stimulating Hormone market size was valued at USD 1312 million in 2023 and is forecast to a readjusted size of USD 1578.8 million by 2030 with a CAGR of 2.7% during review period.

Global Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

Global Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Follicle Stimulating Hormone market size is expected to reach $ 1578.8 million by 2030, rising at a market growth of 2.7% CAGR during the forecast period (2024-2030).

Product Tags

follicle stimulating hormone

follicle stimulating hormone test kit

recombinant follicle stimulating hormone

urinary follicle stimulating hormone

recombinant human follicle stimulating hormone

follicle stimulating hormone fsh elisa test kit

follicle stimulating hormone fsh elisa test kit production demand producers

Follicle Stimulating Hormone (FSH) ELISA Test Kit

Recombinant Human Follicle-stimulating Hormone

Follicle Stimulating Hormone (FSH) Injections

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>